CanniMed ® Ltd. was established in 2013 to provide Canadian patients with access to a standardized and trusted supply of pharmaceutical-grade cannabis as well as new products grown under conditions that comply with pharmaceutical manufacturing standards. Our goal is to provide improved access for Canadians who rely on medical marijuana to manage the symptoms of chronic disabilities and terminal illnesses, while maintaining safety standards and reliability.

Our vision at CanniMed ® Ltd. is to help people with chronic and terminal illnesses improve their quality of life when conventional medicine just isn’t enough. We focus on producing pharmaceutical-grade cannabis through research and development as well as through collaborations with external partners, including academic institutions and healthcare professionals.